Electrical stimulation devices or electronic muscle stimulation devices are essentially electrotherapy devices that are specifically designed to cause muscle contraction via electrical impulses. Non-invasive technology devices have been a major focus area in the past few years of medical device manufacturers, as majority of ESDs available in the market require surgical implantation as well as replacement surgeries after every few years. Factors such as escalating prevalence of chronic medical conditions, increasing geriatric population, introduction of novel technologies are driving the growth of the global electrical stimulation devices market. However, certain factors such as presence of alternative treatment therapies, low endorsement from regulatory bodies, and risks associated with implant procedures might pull back the growth of electrical stimulation devices market.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/1529
Based on device type, the global electrical stimulation devices market has been segmented into spinal cord stimulation (SCS) devices, deep brain stimulation (DBS) devices, vagus nerve stimulation (VNS) devices, sacral nerve stimulation (SNS) devices, gastric electric stimulation (GES) devices, transcutaneous electrical nerve stimulation (TENS) devices, neuromuscular electrical stimulation (NMES/EMS) devices, and other electrical stimulation devices (electrotherapy devices, combination devices, TNS, TMS, etc.). Spinal cord stimulation (SCS) devices dominated the market in 2014 due to increasing number of SCS implantation in the chronic pain management of trunk or limbs, which includes pain associated with post-back surgery syndrome, lower back, or legs coupled with growing incidence of neuromuscular diseases in developed regions. However, the vagus nerve stimulation (VNS) devices segment is expected to grow at the highest CAGR during the forecast period as these devices are becoming extremely important to reduce epilepsy seizures and improve postictal recovery in patients.
Inquiry on this report @ http://www.mrrse.com/enquiry/1529
The application segment in the electrical stimulation devices market has been categorized into pain management, neurological and movement disorder management, musculoskeletal disorders management, metabolism & GIT management (stomach, intestine, pancreas, digestion, blood pressure, nausea, vomiting, gastroparesis, etc.), incontinence management (fecal incontinence, urinary incontinence, urinary retention), and others (aesthetics, training, cosmetics, etc.). Pain management was observed as the largest segment in terms of revenue in 2014. Increasing incidence of chronic pain and other pain among the population and clinical studies supporting the benefits of ESDs boost the usage of these devices in the pain management segment. However, neurological and movement disorder management segment is expected to expand at the highest CAGR during the forecast period due to the increasing incidence of psychiatric disorders such as Parkinson’s disease among population and growing applicability of neural stimulators in various neurological disorders.
Geographically, North America accounted for the largest share of the global electrical stimulation devices market in 2014. Factors attributed to the dominant position of North America in electrical stimulation devices market are growing prevalence of lifestyle-related diseases, increasing number of sports related injuries, increased access to health care, and rising incidence of pain indications among geriatric. However, Asia Pacific is anticipated to witness the highest growth during the forecast period. Key factors such as phenomenally increasing base of aging patient population, increasing disposable income among population in various emerging economies, and greater demand for advanced medical interventions would accentuate the growth of electrical stimulation devices market in Asia Pacific. China is the major market for electrical stimulation devices in Asia Pacific. Factors such as large geriatric population, significant rise in health care spending, large population of disabled people, increase in chronic illnesses, high incidence rate of traffic accidents would boost the growth of the ESDs market in China.
Read Complete Report with TOC @ http://www.mrrse.com/electrical-stimulation-devices-market
The global electrical stimulation devices market is highly competitive and oligopolistic. The prominent companies governing the electrical stimulation devices market are Boston Scientific Corporation, BTL Industries, Inc., Cyberonics, Inc., DJO Global, EnteroMedics Inc., Medtronic plc, Nevro Corp., NeuroMetrix, Inc., St. Jude Medical, Inc., Uroplasty, Inc. (Cogentix Medical), and Zynex, Inc. Easy commercial availability of products, superior distribution channels, and ample supply capabilities are the other major factors that play an important role in determining the market position of these players.
90 State Street,
Albany NY – 12207